மாநாடு ஆவணம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மாநாடு ஆவணம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மாநாடு ஆவணம் Today - Breaking & Trending Today

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ChemoCentryx, Inc.


SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ChemoCentryx, Inc. - CCXI
07/07/2021 | 11:15pm EDT
Send by mail :
Message :
Required fields
NEW YORK, July 07, 2021 (GLOBE NEWSWIRE) Pomerantz LLP is investigating claims on behalf of investors of  ChemoCentryx, Inc. (“ChemoCentryx” or the “Company”) (NASDAQ: CCXI). Such investors are advised to contact Robert S. Willoughby at
The investigation concerns whether ChemoCentryx and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 
On May 4, 2021, the U.S. Food and Drug Administration (“FDA”) released a “Briefing Document” concerning ChemoCentryx’s drug candidate avacopan, which is in development for the treatment of adult patients with anti-neutrophil cytoplasmic autoantibody (ANCA) vasculitis.  To support its New Drug Application for avacopan, ChemoCentryx relied primarily upon its Pha ....

New York , United States , France General , Los Angeles , Abrahaml Pomerantz , Roberts Willoughby , Drug Administration , Pomerantz Firm , Chemocentryx Inc , New Drug Application , Briefing Document , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , லாஸ் ஏஞ்சல்ஸ் , ராபர்ட்ஸ் விருப்பம் , போமேரதண்தஜ் நிறுவனம் , புதியது மருந்து விண்ணப்பம் , மாநாடு ஆவணம் ,